Skip to main content
TipRanks
Go Ultimate75% OFF

Estrella Immunopharma (ESLA) Stock Statistics & Valuation Metrics

48 Followers

Total Valuation

Estrella Immunopharma has a market cap or net worth of $22.36M. The enterprise value is $41.54T.

Market Cap
$22.36M
Enterprise Value
$41.54T

Share Statistics

Estrella Immunopharma has 43,497,864 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
43,497,864
Owned by Insiders
1.75%
Owned by Institutions
2.43%

Financial Efficiency

Estrella Immunopharma’s return on equity (ROE) is 1.26 and return on invested capital (ROIC) is 126.01%.

Return on Equity (ROE)
1.26
Return on Assets (ROA)
-4.11
Return on Invested Capital (ROIC)
126.01%
Return on Capital Employed (ROCE)
1.26
Revenue Per Employee
0
Profits Per Employee
-4.35M
Employee Count
3
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Estrella Immunopharma is -2.09. Estrella Immunopharma’s PEG ratio is -0.11.

PE Ratio
-2.09
PS Ratio
0.00
PB Ratio
-2.97
Price to FCF
-2.38
Price to Operating Cash Flow
-2.36
PEG Ratio
-0.11

Income Statement

In the last 12 months, Estrella Immunopharma had revenue of 0 and earned -13.06M in profits. Earnings per share was -0.35.

Revenue
0
Gross Profit
0
Operating Income
-13.06M
Pretax Income
-13.06M
Net Income
-13.06M
EBITDA
-13.06M
Earnings Per Share (EPS)
-0.35

Cash Flow

In the last 12 months, operating cash flow was -9.38M and capital expenditures 0, giving a free cash flow of -9.38M billion.

Operating Cash Flow
-9.38M
Free Cash Flow
-9.38M
Free Cash Flow per Share
-0.22

Dividends & Yields

Estrella Immunopharma pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-41.97%
Earnings Yield
-45.30%

Stock Price Statistics

Beta
1.93
52-Week Price Change
-76.64%
50-Day Moving Average
0.55
200-Day Moving Average
0.96
Relative Strength Index (RSI)
47.40
Average Volume (3m)
2.00M

Financial Position

Estrella Immunopharma as a current ratio of 0.12, with Debt / Equity ratio of 0.00%

Current Ratio
0.12
Quick Ratio
0.12
Debt to Market Cap
0.00
Net Debt to EBITDA
0.11
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Estrella Immunopharma has paid 838 in taxes.

Income Tax
838
Effective Tax Rate
-0.00

Enterprise Valuation

Estrella Immunopharma EV to EBITDA ratio is -2.27, with an EV/FCF ratio of -2.37.

EV to Sales
0.00
EV to EBITDA
-2.27
EV to Free Cash Flow
-2.37
EV to Operating Cash Flow
-2.37

Balance Sheet

Estrella Immunopharma has $146.67K in cash and marketable securities with $0.00 in debt, giving a net cash position of $146.67K billion.

Cash & Marketable Securities
$146.67K
Total Debt
$0.00
Net Cash
$146.67K
Net Cash Per Share
$0.00
Tangible Book Value Per Share
-$0.17

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Estrella Immunopharma is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
―
EPS Growth Forecast
24.03%